» Articles » PMID: 31487800

Prevalence of Early Chronic Kidney Disease and Main Associated Factors in Spanish Population: Populational Study

Overview
Journal J Clin Med
Specialty General Medicine
Date 2019 Sep 7
PMID 31487800
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to determine the prevalence of early chronic kidney disease (EKD) (stages 1 and 2) and the factors associated. This was a populational study including individuals from 18-75 years randomly selected from 18 Primary Healthcare centers in the area of Barcelonès Nord and Maresme (Catalunya, Spain). Variables: anamnesis, physical examination, blood pressure, and analysis. EKD was defined with by a glomerular filtration rate (GFR) ≥60 mL/min/1.73 m and albumin/creatinine ratio (ACR) ≥17 mg/g in men and ≥25 mg/g in women confirmed with two determinations. 2871 individuals: 43% men, mean age 55 years (19-75), 32.2% obese, 50.5% abdominal obesity, 21.1% hypertensive, and 10.6% diabetic. Prevalence of EKD: With one determination 157 individuals (5.5%), 110 men (9%) and 47 women (2.8%); with two determinations 109 individuals (3.8%), 85 men (7%), and 24 women (1.5%). Factors independently associated with the multivariate logistic regression model: Man (OR 3.35), blood pressure ≥ 135/85 mmHg (OR 2.29), BMI ≥ 30 kg/m (OR 2.48), glycemia ≥ 100 mg/dL (OR 1.73), smoker (OR 1.67) and age (OR 1.04). The prevalence varies if the diagnosis is established based on one or two analytical determinations, overestimated if only one determination is made and depends on the value chosen to define urine albumin excretion.

Citing Articles

Pharmaceutical care program for patients with chronic kidney disease in the community pharmacy: Detection of nephrotoxic drugs and dose adjustment. Viability study.

Escriba-Marti G, Camara-Ramos I, Climent-Catala M, Escudero-Quesada V, Salar-Ibanez L PLoS One. 2022; 17(12):e0278648.

PMID: 36548299 PMC: 9778591. DOI: 10.1371/journal.pone.0278648.


Chronic Kidney Disease: The Silent Epidemy.

Bellasi A, Di Lullo L, Di Iorio B J Clin Med. 2019; 8(11).

PMID: 31717778 PMC: 6912263. DOI: 10.3390/jcm8111795.

References
1.
Coresh J, Selvin E, Stevens L, Manzi J, Kusek J, Eggers P . Prevalence of chronic kidney disease in the United States. JAMA. 2007; 298(17):2038-47. DOI: 10.1001/jama.298.17.2038. View

2.
Fox C, Larson M, Leip E, Culleton B, Wilson P, Levy D . Predictors of new-onset kidney disease in a community-based population. JAMA. 2004; 291(7):844-50. DOI: 10.1001/jama.291.7.844. View

3.
Aranceta-Bartrina J, Perez-Rodrigo C, Alberdi-Aresti G, Ramos-Carrera N, Lazaro-Masedo S . Prevalence of General Obesity and Abdominal Obesity in the Spanish Adult Population (Aged 25-64 Years) 2014-2015: The ENPE Study. Rev Esp Cardiol (Engl Ed). 2016; 69(6):579-87. DOI: 10.1016/j.rec.2016.02.009. View

4.
Otero A, de Francisco A, Gayoso P, Garcia F . Prevalence of chronic renal disease in Spain: results of the EPIRCE study. Nefrologia. 2009; 30(1):78-86. DOI: 10.3265/Nefrologia.pre2009.Dic.5732. View

5.
Heathcote K, Wilson M, Quest D, Wilson T . Prevalence and duration of exercise induced albuminuria in healthy people. Clin Invest Med. 2009; 32(4):E261-5. DOI: 10.25011/cim.v32i4.6616. View